The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
The Pathophysiology and Treatment of Sepsis
Abstract
Sepsis is the leading cause of death in critically ill patients in the United States. Yet the individual host response to septicemia is variable, depending on the patient's immune response, age, nutritional status, and coexisting conditions, as well as on the virulence of the organism and the size of the inoculum. This review examines evolving concepts of sepsis and discusses new and potential therapies. Recent clinical advances include therapy with activated protein C, stringent control of blood glucose, and early goal-directed therapy to treat cellular oxygen deficit. Future therapies may be focused on modulating the immune response in the light of the characteristics of the specific pathogen, the genetic profile of the patient, and the duration of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000) · Nature · doi:10.1038/35013070 · Cited by 4,211
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024
Immunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787
Opal, S. M., & DePalo, V. A. (2000) · Chest · doi:10.1378/chest.117.4.1162 · Cited by 1,752
Ziegler, E. J., Fisher, C. J., Sprung, C. L., Straube, R. C., Sadoff, J. C., Foulke, G. E., Wortel, C. H., Fink, M. P., Dellinger, R. P., Teng, N. N. H., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102143240701 · Cited by 1,611
Pathogenetic Mechanisms of Septic Shock
Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548
A receptor for phosphatidylserine-specific clearance of apoptotic cells
Fadok, V. A., Bratton, D. L., Rose, D. M., Pearson, A., Ezekewitz, R. A. B., & Henson, P. M. (2000) · Nature · doi:10.1038/35011084 · Cited by 1,491
Bone, R. C., Fisher, C. J., Clemmer, T. P., Slotman, G. J., Metz, C. A., Balk, R. A., & The Methylprednisolone Severe Sepsis Study Group (1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171101 · Cited by 1,440
High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial
Warren, B. L., Eid, A., Singer, P., Pillay, S. S., Carl, P., Novak, I., Chalupa, P., Atherstone, A., Pénzes, I., Kübler, A., et al. (2001) · JAMA · doi:10.1001/jama.286.15.1869 · Cited by 1,419
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction
Hotchkiss, R. S., Swanson, P. E., Freeman, B. D., Tinsley, K. W., Cobb, J. P., Matuschak, G. M., Buchman, T. G., & Karl, I. E. (1999) · Critical Care Medicine · doi:10.1097/00003246-199907000-00002 · Cited by 1,340
Self-citationTreatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H., & Benjamin, E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342603 · Cited by 1,241
Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Schmieg, R. E., Hui, J. J., Chang, K. C., Osborne, D. F., Freeman, B. D., Cobb, J. P., Buchman, T. G., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6952 · Cited by 934
Self-citationGogos, C. A., Drosou, E., Bassaris, H. P., & Skoutelis, A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315214 · Cited by 882
The Effects of Ibuprofen on the Physiology and Survival of Patients with Sepsis
Bernard, G. R., Wheeler, A. P., Russell, J. A., Schein, R., Summer, W. R., Steinberg, K. P., Fulkerson, W. J., Wright, P. E., Christman, B. W., Dupont, W. D., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703273361303 · Cited by 837
Genetic and Environmental Influences on Premature Death in Adult Adoptees
Sørensen, T. I. A., Nielsen, G. G., Andersen, P. K., & Teasdale, T. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803243181202 · Cited by 827
Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious Purpura
Girardin, E., Grau, G. E., Dayer, J.-M., Roux-Lombard, P., the J5 Study Group*, & Lambert, P.-H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190703 · Cited by 737
Protection from septic shock by neutralization of macrophage migration inhibitory factor
Calandra, T., Echtenacher, B., Roy, D. L., Pugin, J., Metz, C. N., Hültner, L., Heumann, D., Männel, D., Bucala, R., & Glauser, M. P. (2000) · Nature Medicine · doi:10.1038/72262 · Cited by 723
Raff, M. (1998) · Nature · doi:10.1038/24055 · Cited by 688
Toll-like receptors: key mediators of microbe detection
Underhill, D. M., & Ozinsky, A. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00304-1 · Cited by 681
Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment
Zeni, F., Freeman, B., & Natanson, C. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00001 · Cited by 648
Joyce, D. E., Gelbert, L., Ciaccia, A., DeHoff, B., & Grinnell, B. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100017200 · Cited by 648
Multiple Organ System Failure and Infection in Adult Respiratory Distress Syndrome
BELL, R. C., COALSON, J. J., SMITH, J. D., & JOHANSON, W. G. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-3-293 · Cited by 646
Riedemann, N. C., Guo, R., & Ward, P. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19523 · Cited by 624
Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature
Cronin, L., Cook, D. J., Carlet, J., Heyland, D. K., King, D. B. M., Lansang, M. A. D., & Fisher, Jr. (1995) · Critical Care Medicine · doi:10.1097/00003246-199508000-00019 · Cited by 622
ANIMAL MODELS OF SEPSIS AND SHOCK: A REVIEW AND LESSONS LEARNED
Deitch, E. A. (1998) · Shock · doi:10.1097/00024382-199801000-00001 · Cited by 579
The Acute Respiratory Distress Syndrome
Kollef, M. H., & Schuster, D. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501053320106 · Cited by 550
Laboratory models of sepsis and septic shock
Fink, M. P., & Heard, S. O. (1990) · Journal of Surgical Research · doi:10.1016/0022-4804(90)90260-9 · Cited by 541
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte
Hotchkiss, R. S., Chang, K. C., Swanson, P. E., Tinsley, K. W., Hui, J. J., Klender, P., Xanthoudakis, S., Roy, S., Black, C., Grimm, E., et al. (2000) · Nature Immunology · doi:10.1038/82741 · Cited by 526
Self-citationNormal Responses to Injury Prevent Systemic Inflammation and Can Be Immunosuppressive
MUNFORD, R. S., & PUGIN, J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2007102 · Cited by 522
OʼSullivan, S. T., Lederer, J. A., Horgan, A. F., Chin, D. H. L., Mannick, J. A., & Rodrick, M. L. (1995) · Annals of Surgery · doi:10.1097/00000658-199510000-00006 · Cited by 493
Fisher, C. J., Slotman, G. J., Opal, S. M., Pribble, J. P., Bone, R. C., Emmanuel, G., Ng, D., Bloedow, D. C., & Catalano, M. A. (1994) · Critical Care Medicine · doi:10.1097/00003246-199401000-00008 · Cited by 490
Delayed Hypersensitivity: Indicator of Acquired Failure of Host Defenses in Sepsis and Trauma
MEAKINS, J. L., PIETSCH, J. B., BUBENICK, O., KELLY, R., RODE, H., GORDON, J., & MACLEAN, L. D. (1977) · Annals of Surgery · doi:10.1097/00000658-197709000-00002 · Cited by 486
SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY
Oberholzer, A., Oberholzer, C., & Moldawer, L. L. (2001) · Shock · doi:10.1097/00024382-200116020-00001 · Cited by 481
Gao, F., Gao, E., Yue, T.-L., Ohlstein, E. H., Lopez, B. L., Christopher, T. A., & Ma, X.-L. (2002) · Circulation · doi:10.1161/01.cir.0000012529.00367.0f · Cited by 469
SOLEZ, K., MOREL-MAROGER, L., & SRAER, J.-D. (1979) · Medicine · doi:10.1097/00005792-197909000-00003 · Cited by 462
Prevention of lymphocyte cell death in sepsis improves survival in mice
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Chang, K. C., Cobb, J. P., Buchman, T. G., Korsmeyer, S. J., & Karl, I. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14541 · Cited by 454
Self-citationDownregulation of proinflammatory cytokine release in whole blood from septic patients
Ertel, W., Kremer, J., Kenney, J., Steckholzer, U., Jarrar, D., Trentz, O., & Schildberg, F. (1995) · Blood · doi:10.1182/blood.v85.5.1341.bloodjournal8551341 · Cited by 445
Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of Pathogenesis
Natanson, C., Hoffman, W. D., Suffredini, A. F., Eichacker, P. Q., & Danner, R. L. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-9-199405010-00009 · Cited by 442
Murphy, S. L. (2000) · PubMed · Cited by 429
Protective effects of C5a blockade in sepsis
Czermak, B. J., Sarma, V., Pierson, C. L., Warner, R. L., Huber-Lang, M., Bless, N. M., Schmal, H., Friedl, H. P., & Ward, P. A. (1999) · Nature Medicine · doi:10.1038/10512 · Cited by 404
Depletion of Dendritic Cells, But Not Macrophages, in Patients with Sepsis
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Grayson, M. H., Osborne, D. F., Wagner, T. H., Cobb, J. P., Coopersmith, C., & Karl, I. E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2493 · Cited by 385
Self-citationOverexpression of Bcl-2 in Transgenic Mice Decreases Apoptosis and Improves Survival in Sepsis
Hotchkiss, R. S., Swanson, P. E., Knudson, C. M., Chang, K. C., Cobb, J. P., Osborne, D. F., Zollner, K. M., Buchman, T. G., Korsmeyer, S. J., & Karl, I. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4148 · Cited by 381
Self-citationHotchkiss, R. S., Swanson, P. E., Cobb, J. P., Jacobson, A., Buchman, T. G., & Karl, I. E. (1997) · Critical Care Medicine · doi:10.1097/00003246-199708000-00015 · Cited by 340
Self-citationEskandari, M. K., Bolgos, G., Miller, C., Nguyen, D. T., DeForge, L. E., & Remick, D. G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.9.2724 · Cited by 323
Plasma tumor necrosis factor and mortality in critically ill septic patients
DEBETS, J. M. H., KAMPMEIJER, R., P, M., BUURMAN, W. A., & VAN DER LINDEN, C. J. (1989) · Critical Care Medicine · doi:10.1097/00003246-198906000-00001 · Cited by 321
THE EFFECTS OF INJURY ON THE ADAPTIVE IMMUNE RESPONSE
Lederer, J. A., Rodrick, M. L., & Mannick, J. A. (1999) · Shock · doi:10.1097/00024382-199903000-00001 · Cited by 309
Coopersmith, C. M. (2002) · JAMA · doi:10.1001/jama.287.13.1716 · Cited by 298
Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned
Reinhart, K., & Karzai, W. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00037 · Cited by 288
Apoptosis in sepsis: a new target for therapeutic exploration
OBERHOLZER, C., OBERHOLZER, A., CLARE-SALZLER, M., & MOLDAWER, L. L. (2001) · The FASEB Journal · doi:10.1096/fj.00-058rev · Cited by 271
Cytokine signaling-regulation of the immune response in normal and critically ill states
Oberholzer, A., Oberholzer, C., & Moldawer, L. L. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004001-00002 · Cited by 267
Toll Receptors: a Central Element in Innate Immune Responses
Vasselon, T., & Detmers, P. A. (2002) · Infection and Immunity · doi:10.1128/iai.70.3.1033-1041.2002 · Cited by 235
An Economic Evaluation of Activated Protein C Treatment for Severe Sepsis
Manns, B. J., Lee, H., Doig, C. J., Johnson, D., & Donaldson, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa020969 · Cited by 234
Severe Sepsis — A New Treatment with Both Anticoagulant and Antiinflammatory Properties
Matthay, M. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441009 · Cited by 213
Nelson, S., Belknap, S. M., Carlson, R. W., Dale, D., DeBoisblanc, B., Farkas, S., Fotheringham, N., Ho, H., Marrie, T., Movahhed, H., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515694 · Cited by 204
Afebrile bacteremia. A phenomenon in geriatric patients
Gleckman, R. A. (1982) · JAMA · doi:10.1001/jama.248.12.1478 · Cited by 202
Root, R. K., Lodato, R. F., Patrick, W., Cade, J. F., Fotheringham, N., Milwee, S., Vincent, J.-L., Torres, A., Rello, J., & Nelson, S. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000048629.32625.5d · Cited by 196
Selective defects of T lymphocyte function in patients with lethal intraabdominal infection
Heidecke, C.-D., Hensler, T., Weighardt, H., Zantl, N., Wagner, H., Siewert, J.-R., & Holzmann, B. (1999) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)00183-x · Cited by 180
Hatherill, M., Tibby, S. M., Turner, C., Ratnavel, N., & Murdoch, I. A. (2000) · Critical Care Medicine · doi:10.1097/00003246-200007000-00068 · Cited by 178
Resistance to Acute Septic Peritonitis in Poly(ADP-ribose) Polymerase-1-Deficient Mice
Soriano, F. G., Liaudet, L., Szab??, ?., Vir??g, L., Mabley, J. G., Pacher, P., & Szab??, C. (2002) · Shock · doi:10.1097/00024382-200204000-00008 · Cited by 172
The Toll of Innate Immunity on Microbial Pathogens
Modlin, R. L., Brightbill, H. D., & Godowski, P. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402312 · Cited by 157
Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis
Guo, R., Huber-Lang, M. S., Wang, X., Sarma, V. J., Padgaonkar, V. A., Craig, R. A., Riedemann, N. C., McClintock, S. D., Hlaing, T., Shi, M. M., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10793 · Cited by 152
The relationship of pre mortem diagnoses and post mortem findings in a surgical intensive care unit
Mort, T. C., & Yeston, N. S. (1999) · Critical Care Medicine · doi:10.1097/00003246-199902000-00035 · Cited by 151
Cytokine and cytokine receptor polymorphisms in infectious disease
van Deventer, S. J. H. (2000) · Intensive Care Medicine · doi:10.1007/s001340051125 · Cited by 136
Protective effects of anti‐C5a peptide antibodies in experimental sepsis
Huber-Lang, M. S., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Younkin, E. M., Laudes, I. J., Riedemann, N. C., Younger, J. G., et al. (2001) · The FASEB Journal · doi:10.1096/fj.00-0653fje · Cited by 133
THE INDUCTION OF ACCELERATED THYMIC PROGRAMMED CELL DEATH DURING POLYMICROBIAL SEPSIS
Ayala, A., Herdon, C. D., Lehman, D. L., DeMaso, C. M., Ayala, C. A., & Chaudry, I. H. (1995) · Shock · doi:10.1097/00024382-199504000-00003 · Cited by 131
Search for Sepsis Drugs Goes on Despite Past Failures
Stone, R. (1994) · Science · doi:10.1126/science.8153620 · Cited by 130
Green, D. R., & Beere, H. M. (2000) · Nature · doi:10.1038/35011175 · Cited by 128
Warren, H. S., Amato, S. F., Fitting, C., Black, K. M., Loiselle, P. M., Pasternack, M. S., & Cavaillon, J. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.1.89 · Cited by 128
Corticosteroids for septic shock
Annane, D. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00036 · Cited by 126
Fisher, C. J., MARRA, M. N., Palardy, J. E., et al. (1994) · Critical Care Medicine · doi:10.1097/00003246-199404000-00008 · Cited by 122
Strategies for the Treatment of Sepsis
Warren, H. S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703273361311 · Cited by 117
Manjuck, J., Saha, D. C., Astiz, M. E., Eales, L., & Rackow, E. C. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.104306 · Cited by 116
Oberholzer, C., Oberholzer, A., Bahjat, F. R., Minter, R. M., Tannahill, C. L., Abouhamze, A. S., LaFace, D., Hutchins, B., Clare-Salzler, M. J., & Moldawer, L. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181338198 · Cited by 114
Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury
O'Suilleabhain, C., O’Sullivan, S. T., Kelly, J. L., et al. (1996) · Surgery · doi:10.1016/s0039-6060(96)80300-x · Cited by 109
Weighardt, H., Heidecke, C.-D., Emmanuilidis, K., Maier, S., Bartels, H., Siewert, J., & Holzmann, B. (2000) · Surgery · doi:10.1067/msy.2000.104118 · Cited by 103
Immunomodulatory Role of CXCR2 During Experimental Septic Peritonitis
Ness, T. L., Hogaboam, C. M., Strieter, R. M., & Kunkel, S. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3775 · Cited by 103
Goldfarb, R. D., Marton, A., Szabó, É., Virág, L., Salzman, A. L., Glock, D., Akhter, I., McCarthy, R. J., Parrillo, J. E., & Szabó, C. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205000-00004 · Cited by 102
Relevance of Fcγ Receptor and Interleukin‐10 Polymorphisms for Meningococcal Disease
van der Pol, W. L., Huizinga, T. W. J., Vidarsson, G., van der Linden, M. W., Jansen, M., Keijsers, V., de Straat, F. G. J. L.-V., WESTERDAAL, N. A. C., van de Winkel, J. G. J., & Westendorp, R. G. J. (2001) · The Journal of Infectious Diseases · doi:10.1086/324662 · Cited by 102
Pruitt, J. H., Welborn, M. B., Edwards, P., Harward, T. R. S., Seeger, J., Martin, T., Smith, C. A., Kenney, J. P., Wesdorp, R. I. C., Meijer, S., et al. (1996) · PubMed · doi:10.1182/blood.v87.8.3282.bloodjournal8783282 · Cited by 100
Janes, K. A., Albeck, J. G., Peng, L., Sorger, P. K., Lauffenburger, D. A., & Yaffe, M. B. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300045-mcp200 · Cited by 99
Echtenacher, B., Weigl, K., Lehn, N., & Männel, D. N. (2001) · Infection and Immunity · doi:10.1128/iai.69.6.3550-3555.2001 · Cited by 96
Thomas, L. (1972) · New England Journal of Medicine · doi:10.1056/nejm197209142871109 · Cited by 96
Adrenal Insufficiency in Critically Ill Patients
Shenker, Y., & Skatrud, J. B. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2012022 · Cited by 95
Ma, R., Coyle, S., Oldenburg, H. S. A., Rock, C. S., Ps, B., Kj, V. Z., Smith, C. G., Moldawer, L. L., & Sf, L. (1994) · PubMed · Cited by 94
Relationships between T Lymphocyte Apoptosis and Anergy Following Trauma
Pellegrini, J. D., De, A. K., Kodys, K., et al. (2000) · Journal of Surgical Research · doi:10.1006/jsre.1999.5797 · Cited by 81
Hagberg, L., Briles, D. E., & Edén, C. S. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.6.4118 · Cited by 80
ENDOTOXIN, SEPSIS, AND THE PRIMROSE PATH
O??Reilly, M., Newcomb, D. E., & Remick, D. G. (1999) · Shock · doi:10.1097/00024382-199912000-00001 · Cited by 78
Glucocorticoid-induced, caspase-dependent organ apoptosis early after burn injury
Fukuzuka, K., Edwards, C. K., Clare-Salzler, M. J., Copeland, E. M., Moldawer, L. L., & Mozingo, D. W. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.278.4.r1005 · Cited by 76
Potentia Hazards of Combination Immunotherapy in the Treatment of Experimental Septic Shock
Opal, S. M., Cross, A. S., Jhung, J. W., Young, L. D., Palardy, J., Parejo, N. A., & Donsky, C. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.6.1415 · Cited by 62
Ertel, W., Mh, M., Ayala, A., Dean, R. E., & Ih, C. (1992) · PubMed · Cited by 61
Liposomal NAD+prevents diminished O2consumption by immunostimulated Caco-2 cells
Khan, A. U. H., Delude, R. L., Han, Y. Y., Sappington, P. L., Han, X., Carcillo, J. A., & Fink, M. P. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00358.2001 · Cited by 57
Myocardial Hibernation: Restorative or Preterminal Sleep?
Sawyer, D. B., & Loscalzo, J. (2002) · Circulation · doi:10.1161/01.cir.0000014689.12415.89 · Cited by 43
Corticosteroids and Septic Shock
Abraham, E. H. (2002) · JAMA · doi:10.1001/jama.288.7.886 · Cited by 36
Ronco, C., Bellomo, R., & Lonneman, G. (2003) · New England Journal of Medicine · doi:10.1056/nejm200304173481616 · Cited by 30
Cited by
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Petrilli, C. M., Jones, S. A., Yang, J., Rajagopalan, H., O’Donnell, L., Chernyak, Y., Tobin, K. A., Cerfolio, R. J., Francois, F., & Horwitz, L. I. (2020) · BMJ · doi:10.1136/bmj.m1966 · Cited by 3,054
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772
Self-citationCecconi, M., Evans, L., Levy, M., & Rhodes, A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30696-2 · Cited by 2,254
ESPEN guidelines on parenteral nutrition: intensive care
Singer, P., Berger, M. M., Van den Berghe, G., Biolo, G., Calder, P., Forbes, A., Griffiths, R., Kreyman, G., Leverve, X., & Pichard, C. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.04.024 · Cited by 1,907
Metadata
- Authors
- Hotchkiss, R. S., & Karl, I. E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-01-09
- Volume
- 348
- Issue
- 2
- Pages
- 138-150
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1977905350
- Cited by
- 4,097
- References
- 107
- FWCI
- 127.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.